FDA Logo links to FDA home pageU.S. Food and Drug Administration
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizonal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizonal rule

Prescription Drug User Fee Act (PDUFA)

FDA PDUFA Information

horizonal rule

Billable Products

 

PDUFA Guidances / Rules

 

Performance Reports

 

PDUFA III

PDUFA III Five-Year Plan - July, 2003

    FEDERAL REGISTER Prescription Drug User Fee Act III Five-Year Plan; Availability - 10/14/2003 - (PDF), (Text)

PDUFA Reauthorization Performance Goals and Procedures

Prescription Drug User Fee Amendments of 2002

PDUFA III Letter - Tommy Thompson - 6/4/2002 - (Text)

 

PDUFA II

PDUFA II Meeting 2000: Consulting with Stakeholders - 9/15/2000

PDUFA II Five-Year Plan - July, 1998

    PDUFA II Five-Year Plan - FY 1999 Revision - July 1999 - Describes plans to achieve the new goals associated the the Prescription Drug User Fee Act of 1992 (PDUFA), as amended and extended through the year 2002 by the Food and Drug Modernization Act of 1997.

    PDUFA II Five-Year Plan - FY 2000 Update - July 2000 - Provides background information on PDUFA and a summary of the PDUFA II goals, and discusses the 10 major assumptions on which the plan is based and how those assumptions have changed since the original plan was issued in 1998.

PDUFA II Letter - Donna Shalala - 11/12/1997 - (Text)

PDUFA II Reauthorization Performance Goals and Procedures - 11/12/1997 - (Text) - (PDF)

 

User Fee Rates

FEDERAL REGISTER Establishment of Prescription Drug User Fee Rates

 
horizonal rule